Clinical Trial Update: Multi-day (3) In-patient Evaluation of Intradermal Versus Subcutaneous Basal and Bolus Insulin Infusion [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 1/2 clinical trial evaluating intradermal versus subcutaneous basal and bolus insulin infusion in diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: Becton, Dickinson and Company | Conditions: Diabetes | Phase 1, Phase 2 | Status: COMPLETED